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Fast and easy isolation and sorting of glial nuclei from the mouse brain
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Reproducible and versatile processing of enriched nuclei for omics applications
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ABSTRACT

31

Background

32
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Isolation of cell types of interest from the brain for molecular applications presents several
challenges, including cellular damage during tissue dissociation or enrichment procedures, and
low cell number in the tissue in some cases. Techniques have been developed to enrich distinct
cell populations using immunopanning or fluorescence activated cell/nuclei sorting. However,
these techniques often involve fixation, immunolabeling and DNA staining steps, which could
potentially influence downstream omics applications.

38

New Method

39
40
41
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43
44

Taking advantage of readily available genetically modified mice with fluorescent-tagged
nuclei, we describe a technique for the purification of cell-type specific brain nuclei, optimized
to decrease sample preparation time and to limit potential artefacts for downstream omics
applications. We demonstrate the applicability of this approach for the purification of glial cell
nuclei and show that the resulting cell-type specific nuclei obtained can be used effectively for
omics applications, including ATAC-seq and RNA-seq.

45

Results

46
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53

We demonstrate excellent enrichment of fluorescently-tagged glial nuclei, yielding high
quality RNA and chromatin. We identify several critical steps during nuclei isolation that help
limit nuclei rupture and clumping, including quick homogenization, dilution before filtration
and loosening of the pellet before resuspension, thus improving yield. Sorting of fluorescent
nuclei can be achieved without fixation, antibody labelling, or DAPI staining, reducing
potential artifactual results in RNA-seq and ATAC-seq analyses. We show that reproducible
glial cell type-specific profiles can be obtained in transcriptomic and chromatin accessibility
assays using this rapid protocol.

54

Comparison with existing methods

55
56
57

Our method allows for rapid enrichment of glial nuclei populations from the mouse brain with
minimal processing steps, while still providing high quality RNA and chromatin required for
reliable omics analyses.

58

Conclusions
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We provide a reproducible method to obtain nucleic material from glial cells in the mouse brain
with a quick and limited sample preparation.
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68

1. INTRODUCTION

69

Glial cells regulate essential processes of the central nervous system during development

70

and in the adult brain like myelination, immune response, dendritogenesis, neuromodulation,

71

and synapse formation, maturation and elimination (Matejuk and Ransohoff, 2020; Vainchtein

72

and Molofsky, 2020). Of the different glial cells, astrocytes, oligodendrocytes and microglia

73

are the most studied, due to their different roles in the nervous system physiology and disease

74

(Allen and Lyons, 2018). Astrocytes directly form signalling networks with neurons (Durkee

75

and Araque, 2019) and are therefore integral to nervous tissue function, including synapse

76

formation and maintenance (Allen and Eroglu, 2017). Microglia are the resident immune cells

77

of the brain but also participate in neuronal development, synaptogenesis and synapse

78

maturation, through pruning and the release of molecules including nerve growth factor and

79

tumor necrosis factor (Matejuk and Ransohoff, 2020; Reemst et al., 2016). Oligodendrocyte

80

precursor cells (OPCs) not only differentiate into oligodendrocytes responsible for myelination

81

throughout life but are also able to form synapses with neurons and may establish bidirectional

82

communication (Sakry et al., 2014, 2011). Oligodendrocytes form the myelin sheath,

83

regulating conduction across the axon, but can also regulate synaptic transmission through

84

potassium clearance and the release of factors like brain derived neurotrophic factor (Xin and

85

Chan, 2020).

86

The differentiation, maturation and function of glial cells are tightly regulated by changes

87

in their chromatin and transcriptome (Hammond et al., 2019; Lattke et al., 2021; Marques et

88

al., 2018). Epigenetic changes during development direct cell fate and, after maturation,

89

regulate cellular function through regulation of the transcriptome (Bayraktar et al., 2015; Eggen

90

et al., 2019; Tiane et al., 2019). There is also increasing evidence that continuous and plastic

91

communication exists between different types of glia throughout life, highlighting the need to

92

understand cell type-specific contributions and changes (Domingues et al., 2016; Nutma et al.,

3
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2020; Vainchtein and Molofsky, 2020). The exploration of the transcriptome of glial cells and

94

the correlation to chromatin architecture is therefore a key area of investigation that will expand

95

our understanding of the role of these cells in physiological conditions and disease.

96

In vivo studies in the mouse brain provide several advantages over culture, the most salient

97

being the ability to amalgamate all signals and their consequences in a complete system.

98

However, in vivo molecular studies have been hampered by the heterogeneity of brain tissue,

99

preventing the assignment of particular alterations to specific cell types (Maze et al., 2014).

100

The size of the cell type population is also relevant for glial cells, which tend be fewer

101

compared to neurons, or expression and chromatin differences might be confounded by higher

102

levels in other cell types. Therefore, a necessary step for omics studies of brain cells is to purify,

103

or at least enrich, for a cell type of interest prior to molecular analyses. To this end, several

104

methods have been developed to enrich for particular cell types of interest, include sorting of

105

immunolabelled cells or nuclei of the desired cell type (Douvaras and Fossati, 2015; Holt and

106

Olsen, 2016; John Lin et al., 2017).

107

The first step in many protocols involves an enzymatic digestion to dissociate brain tissue

108

into cell suspensions. The digestion time and type of enzymes must be carefully optimized to

109

minimize loss of antigen targets of antibodies used in subsequent steps (Barres, 2014).

110

Although these methods allow the isolation of whole cells, loss of membrane integrity from

111

sheer stress can induce stress signals and could alter chromatin structure and gene expression

112

profiles (Mo et al., 2015). Once a cell suspension is obtained, different approaches can be used

113

to enrich for a specific cell type. Immunopanning is commonly used for this purpose and

114

involves sequential plating of cell suspensions on antibody-coated plates to deplete cell

115

populations based on membrane markers (Foo et al., 2011). This approach is most suitable to

116

maintain and study these cell populations in culture; however, transcriptional changes are

117

known to occur in vitro, and might not reflect the state of the cell prior to cell collection.
4
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Alternatively, cells can be either labeled with fluorophore-tagged antibodies and isolated using

119

fluorescence-activated cell sorting (Cahoy et al., 2008; Guez-Barber et al., 2012), or labeled

120

with magnetically tagged antibodies and isolated with magnetic-activated cell sorting (MACS,

121

(Marek et al., 2008). Although these methods allow good enrichment of populations, changes

122

in transcription and chromatin structure could occur due to the initial dissociation steps and

123

prolonged manipulation. Both FACS and MACS require incubation periods with antibodies,

124

and sorting might require long periods of time or multiple elution rounds in the case of MACS

125

(Chongtham et al., 2021). Another limitation is that each glial cell type is itself heterogeneous,

126

making it challenging to find antibodies that will select for all sub-populations. (Marques et

127

al., 2016; Matias et al., 2019). In order to limit disruptions caused by stress response inherent

128

to the cell dissociation step, it is possible to instead quickly dissociate all cell membranes to

129

isolate nuclei (Binek et al., 2019; Chongtham et al., 2021; Mo et al., 2015). Similar to whole

130

cells, cell type -specific nuclei can be labeled with antibodies and sorted. While early studies

131

simply used NeuN to obtain neuronal and non-neuronal populations (Jiang et al., 2008),

132

specific cell-type nuclear markers have been used for oligodendrocytes (Mendizabal et al.,

133

2019) and microglia (Nott et al., 2019). Although changes in the chromatin and transcriptome

134

caused by signals from outside the nuclei would be removed, serial incubations and

135

manipulation may still affect yield by breaking the nuclei.

136

To avoid the use of antibodies, genetic approaches emerged to tag cells or nuclei of interest

137

with fluorescent proteins. The commercially available mice B6;129-Gt(ROSA)26Sortm5(CAG-

138

Sun1/sfGFP)Nat/J

139

protein (GFP) and SUN1 nuclear lamina fusion protein that can be used to fluorescently tag

140

nuclei of interest using cell-type specific Cre lines of mice (Mo et al., 2015). Available

141

protocols for isolation and fluorescence activated nuclei sorting (FANS) require prolonged

142

processing and manipulation before enrichment. To obtain nuclei suspensions, these methods

(Mo et al., 2015), referred as Sun1-GFP , have a Cre-sensitive green fluorescent

5
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143

use time-consuming ultracentrifugation, as long as 2.5 h in gradients (Percoll or iodixanol) that

144

might be expensive or not readily available (Jiang et al., 2008). In addition, several protocols

145

stain nuclei with dyes like DAPI or propidium iodide to help remove doublets during sorting

146

that could interfere with downstream applications (Chongtham et al., 2021; Mo et al., 2015).

147

Here, we present a time saving procedure for isolation of fluorescent nuclei that uses a

148

readily available sucrose gradient, and does not require fixation, ultracentrifugation or other

149

prolonged manipulations and incubations. We show that this method is suitable for glial cells,

150

providing high yield of nuclei with limited clumping. Furthermore, high enrichment of

151

fluorescent nuclei using FANS was achieved by removing nuclei doublets without the use of

152

dyes or additional antibodies. Finally, we also show that the enriched nuclei can be used for

153

omics analysis, as RNA sequencing and assay for transposase-accessible chromatin followed

154

by

155

OPCs/oligodendrocytes and microglia. Our simplified workflow limits complications during

156

nuclei enrichment, prevents possible artefacts in downstream applications and provides high

157

quality RNA and chromatin for omics analyses

sequencing

(ATAC-seq)

revealed

profiles

characteristic

of

astrocytes,

158
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159

2. MATERIALS AND METHODS

160

2.1 Animals

161

All procedures involving animals were conducted in accordance with the regulations of the

162

Animals for Research Act of the province of Ontario, Canada and approved by the University

163

of Western Ontario Animal Care and Use Committee (2017-048). Mice were exposed to 12-

164

hour light/12-hour dark cycles and fed ad libitum with tap water and regular chow.

165

The

166

Gt(ROSA)26Sortm5(CAG-Sun1/sfGFP)Nat/J, IMSR JAX:021039, MGI:5614796) (Mo et al. 2015).

167

Homozygous Sun1-GFP female mice were mated with male mice heterozygous for the

168

tamoxifen-inducible Cre recombinase gene under the control of promoters specific for each

169

glial cell type used: B6 Glast-CreER (Tg(Slc1a3-cre/ERT)1Nat, IMSR JAX:012586,

170

MGI:4430111)

171

icre/ERT2)388Wdr, IMSR JAX:027651, MGI:5634390) for OPCs (McKenzie et al., 2014),

172

and CX3CR11-CreER (B6.129P2(Cg)-Cx3cr1tm2.1(cre/ERT2)Litt/WganJ, ISMR JAX:021160,

173

MGI:5617710) for microglia (Parkhurst et al., 2013).

174

2.2 Genotyping

175

Genomic DNA from ear punches was extracted by incubating samples with DirectPCR Lysis

176

Reagent (Viagen 102-T) and Proteinase K at 55°C overnight. DNA was amplified using

177

primers specific to different genetically engineered alleles (Supplementary Table 1) using

178

FroggaMix (FroggaBio FBTAQM). PCR conditions started with 95°C for 3 min, followed by

179

34 cycles of 95°C for 10s, 57°C for 20s and 72°C for 1min, ending with 72°C for 5 minutes.

180

2.3 Tamoxifen administration

181

Tamoxifen (10 mg, Sigma T5648) was mixed with 100 µl 95% Ethanol, incubated at 60°C

182

until dissolved and diluted with 900 µl corn oil (Sigma C8267). Tamoxifen was injected

183

intraperitoneally to induce Cre recombinase expression in different glial cell types. For OPCs

184

and oligodendrocytes, Sun1-GFP lactating mothers crossed with Sox10-CreER males were

Sun1-GFP

mice

for

were

astrocytes

obtained

(Slezak

from

et

the

al.,

Jackson

2007),

Laboratories

Sox10-CreER

(B6;129-

(Tg(Sox10-
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185

injected with 2 mg tamoxifen for three consecutive days; for astrocytes, post-natal day 10

186

Glast-CreER;Sun1-GFP male pups were injected with 1 mg tamoxifen for three consecutive

187

days; for microglia, 6 week-old CX3CR11-CreER;Sun1-GFP male mice were injected with 2

188

mg for five consecutive days.

189

2.4 Tissue collection and nuclei isolation

190

Mouse brains were dissected in ice cold phosphate buffered saline (PBS) and samples were

191

frozen on dry ice before being stored at -80°C. Tissue was collected from tamoxifen-treated

192

20-day old Sox10-Cre;Sun1-GFP males (forebrain), 1 month-old Glast-Cre;Sun1-GFP male

193

mice (cortex) and from 2 month-old Cx3cr1-Cre;Sun1-GFP male mice (cortex and

194

hippocampus). For nuclei isolation, the solutions were made fresh before each experiment

195

using DEPC water (diethyl pyrocarbonate, Sigma D5758) and kept on ice. Frozen tissue was

196

homogenized in 500µl of homogenization buffer [HB, 20 mM Tricine KOH, 25 mM MgCl2,

197

250 mM sucrose, 1 mM DTT, 0.15 mM spermine, 0.5 mM spermidine, 0.1% IGEPAL-630, 1x

198

protease inhibitor (Millipore Sigma 11873580001), 1 µl/ml RNaseOUT™ RNase inhibitor

199

(Thermo Fisher Scientific 10777019)] with a pestle homogenizer for approximately one minute

200

until a fine suspension was visible. The sample was then diluted to 7.5 ml with HB, filtered

201

through a 40 µm strainer (Falcon 08-771-1) and carefully pipetted over 7.5 ml of cushion buffer

202

[CB, 0.5 mM MgCl2, 0.88 M sucrose, 0.5 mM DTT, 1x protease Inhibitor (Millipore Sigma

203

11873580001), 1 µl/ml RNaseOUT™ RNase inhibitor (Thermo Fisher Scientific 10777019)].

204

Samples were centrifuged at 2800 x g for 20 mins at 4°C to pellet nuclei. The supernatant was

205

carefully removed, and the pelleted nuclei were incubated for 10 min in resuspension buffer

206

[RB, 500 µl 4% FBS, 0.15 mM spermine, 0.5 mM spermidine, 1 ul/ml RNaseOUT™ RNase

207

inhibitor (Thermo Fisher Scientific 10777019) in PBS] and mixed by gentle pipetting.

208
209
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210

2.5 Fluorescence activated nuclei sorting

211

Samples were filtered through a 20 µm strainer (pluriStrainer 43-10020-60) before sorting on

212

a Sony SH800 Cell Sorter with a 100 µm nozzle, and the following gains for the sensors:

213

FSC:14, BSC: 35%, FL1(EGFP):38%. Gating is initially set to discard larger events. Next,

214

GFP intensity was plotted against GFP fluorescence area to eliminate doublets and nuclei

215

clusters by discarding events with higher area. From this final gating step, events with lower

216

GFP intensity were discarded to increase purity of the collected nuclei. Sample volumes

217

sometimes needed to be adjusted with RB in order to maintain a constant flow of events per

218

second. Sorting of the sample was paused throughout the session as needed to resuspend the

219

sample and avoid clumping of the nuclei. For RNA extraction, sorting was also paused to mix

220

the sorted nuclei with the lysis buffer in the collection tubes (described below). To assess the

221

enrichment of GFP+ nuclei in the final sorted nuclei population, 5000 to 10000 nuclei were

222

collected in PBS and an aliquot of the suspension was mixed with 1µg/ml DAPI and placed on

223

a glass slide. The proportion of GFP+ nuclei was quantified with an inverted microscope (DMI

224

6000b, Leica) and digital camera (ORCA-ER, Hamamatsu).

225

2.6 RNA purification and RNA-seq library preparation

226

Sorted Sun1-GFP+ nuclei were collected in 100 µl lysis buffer from the Single cell RNA

227

purification kit (NorgenBiotek 51800) with 2% β-mercaptoethanol. Immediately after sorting,

228

additional lysis buffer was added to reach 600 µl of total lysate volume, as well as 600 µl 70%

229

ethanol. RNA purification was performed according to the manufacturer’s instructions,

230

including an in-column DNase treatment. Samples were eluted twice from the column with 8-

231

12 µl of elution buffer. RNA concentration was determined using Qubit fluorometer

232

(Invitrogen) according to the manufacturer’s instructions using 1-2 µl of sample. RNA integrity

233

was determined using an Agilent Bioanalyzer. Libraries from microglia samples were

234

constructed using 35 ng of RNA with the VAHTS Universal V8 RNA-seq Library Prep Kit for

9
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235

Illumina (Vazyme NR605-01), while astrocyte and OPC/oligodendrocyte libraries were made

236

with 90 ng of RNA using VAHTSTM Total RNA-seq (H/M/R) Library Prep Kit for Illumina

237

(Vazyme NR603-01) following the manufacturer’s instructions.

238

2.7 Assay for transposase-accessible chromatin (ATAC)

239

Approximately 150,000 sorted Sun1-GFP+ nuclei were collected in 50 µl of RNase free PBS.

240

To concentrate the nuclei, the suspension was centrifuged at 3,000 rpm for 5 minutes at 4°C.

241

The supernatant was then carefully removed, and nuclei were resuspended in tagmentation

242

buffer containing Tn5 transposase (Vazyme TD501) for 45 min. at 37°C. Column purification

243

of the samples was quickly performed with QIAquick PCR Purification Kit (Qiagen 28104) to

244

end the tagmentation reaction. Enrichment and purification of the libraries was done according

245

to the TruePrep DNA kit instructions. Quantitative PCR was used to determine the number of

246

enrichment cycles to reach one third saturation, and all the libraries were amplified with more

247

than 12 PCR cycles. Clean-up of all sequencing libraries was performed with SPRIselect beads

248

(Beckman Coulter). The size and purity of the libraries were assessed using an Agilent

249

bioanalyzer before storing at -80°C.

250

2.8 Deep sequencing and data analysis

251

Pooled equimolar libraries were sequenced at Canada’s Michael Smith Genome Sciences

252

Centre (BC Cancer Research, Vancouver, BC, Canada, https://www.bcgsc.ca) using the

253

Illumina Hiseq (Illumina Inc., San Diego, CA). The libraries were sequenced as a 150 bp paired

254

end run. 50 million paired-end reads were obtained for RNA-seq and 100 million paired-end

255

reads for ATAC-seq. Raw reads were pre-processed using Cutadapt and mapped against Mus

256

musculus GRCm39 with HISAT2 for RNA-seq and bowtie2 for ATAC-seq. SAMtools was

257

used to sort and convert SAM files. Gene abundance for RNA-seq was calculated using

258

StringTie. ATAC-seq peaks were visualized using the Integrative genomic viewer IGV (Broad

259

Institute). Heatmaps of differential gene expression from RNA-seq data were generated using

10
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260

Heatmapper (Babicki et al., 2016) with single linkage hierarchical clustering and spearman

261

rank correlation. Expression enrichment of cell type-specific transcription factors was

262

calculated using the cell type-enriched lists and method described in Zhang et al., 2014. Briefly,

263

by dividing the average for each cell type by the sum of the averages of the other cell types.

11
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264

3

RESULTS AND DISCUSSION

265

We used available transgenic mice to obtain brain tissue with GFP tagged nuclei in astrocytes,

266

microglia or OPC/oligodendrocytes. Optimized nuclei isolation was used to obtain nuclei

267

suitable for FANS (Figure 1A). Sorted nuclei were then used for RNA or chromatin extraction,

268

followed by the corresponding procedures for RNA-seq and ATAC-seq (Figure 1B).

269
270

271
272

Figure 1. Protocol overview. (A) Tamoxifen-treated mice that express Sun1-GFP in astrocytes,

273

OPC/oligodendrocytes or microglia are sacrificed, and brain tissue dissected and snap frozen.

274

After tissue homogenization, nuclei are isolated by centrifugation and sorted to enrich for

275

Sun1-GFP-tagged nuclei. (B) Sun1-GFP nuclei are immediately processed for total RNA

276

extraction or chromatin accessibility assay (ATAC-seq) using Tn5. Ribosomal RNA is

277

depleted from total RNA samples before generation of the RNA-seq libraries.

278
279
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280

3.1 Nuclei isolation and sorting

281

We based this nuclei isolation protocol on the method previously published by (Mo et al.,

282

2015). We observed loss of nuclei through homogenization and centrifugation steps, probably

283

due to astringent conditions that affected nuclei integrity. To address this, we optimized the

284

homogenization step and chose a nuclei pelleting centrifugation with sucrose gradient instead

285

of a iodixanol gradient interlayer collection (Figure 2A). We modified the amount of detergent

286

and length of dounce homogenization to maximize yield and integrity of the nuclei while

287

limiting aggregation and clumping caused by leakage of the intranuclear material from ruptured

288

nuclei (Maitra et al., 2021). To determine optimal detergent concentration and dounce time,

289

frozen cortex tissue was homogenized in HB with 0.1%, 0.3% or 0.5% IGEPAL (Figure 2B).

290

Samples were collected throughout the homogenization, stained with DAPI and quantified

291

under a microscope. We observed that homogenization with 0.1% IGEPAL yielded the

292

maximum number of nuclei with a dounce time of 105 s (Figure 2B and 2C). However, we

293

observed that nuclei aggregation also increased with dounce time, potentially from rupture and

294

leakage of a subset of nuclei. This clumping caused problems in the following steps, as it

295

clogged filters during the filtration steps before sorting and ultimately decreased the final yield.

296

Nuclei aggregates would also affect the sorting step, as they block the line or, if sorted, decrease

297

purity. To prevent clumping of the nuclei, we used a dounce time of 1 min and pipetting was

298

kept to a minimum with all nuclei suspensions. The nuclei yield obtained was enough for

299

downstream applications with no clumping and minimal nuclei loss.

300

In addition to detergent concentration and dounce time during homogenization, we found that

301

a key step to obtain high yield was dilution of the nuclei suspension prior to filtration. The

302

nuclei dilution at this step prevents clumping, clogging of the strainer and diminishes loss of

303

nuclei. Furthermore, nuclei yield was significantly improved by increasing the dilution of the

304

suspension to 1:5 (Figure 2D). We used an equivalent volume of a sucrose gradient (CB) and
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305

pelleted the nuclei, as we found this approach more efficient, cost-effective, and direct than

306

using commercial gradients such as iodixanol. These gradients require ultracentrifugation and

307

collection of the interlayer, which is difficult to visualize and obtain without leaving nuclei in

308

the gradient, leading to reduced yield. Nuclei pelleting with a sucrose gradient circumvents

309

these difficulties and allows nuclei resuspension in a buffer compatible with subsequent sorting

310

steps. We also found that a 10 min incubation in buffer before resuspension limited nuclei

311

rupture and clumping. Adding a filtration step just before sorting also decreased clumping

312

issues (Figure 2A).

313
314

Figure 2. Nuclei isolation protocol. (A) Snap frozen brain tissue is homogenized with a pestle

315

homogenizer. The sample is diluted before filtration and transferred to a sucrose gradient.

316

Nuclei are pelleted through centrifugation, filtered and immediately sorted using a Sony SH800

317

Cell Sorter. (B) Maximum number of nuclei obtained throughout homogenization with

318

different detergent concentrations. (C) Nuclei counts and aggregation increase with dounce

319

time, GFP+ enrichment as percentage of the maximum number obtained. (D) Nuclei yield after
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320

filtration increases with dilution, enrichment as percentage of the nuclei counted before

321

filtration.

322
323

For FANS, we first gated the majority of events detected in the forward and back scatter

324

channels, excluding larger events that could represent aggregated nuclei (Figure 3A). As an

325

alternative to the use of dyes like DAPI to detect and remove doublets and smaller clusters, we

326

plotted GFP signal intensity versus area using the population from the first gating (Figure 3B).

327

Singlets appear in the plot in a linear distribution, which were selected to exclude events below

328

the line (doublets) and close to the origin (GFP-). These settings identify the population of

329

Sun1-GFP+ nuclei singlets in the suspension without any additional treatment or manipulation

330

of the isolated nuclei. The gatings were optimized using GFP- samples, to further determine

331

the background levels of signal. Finally, to increase purity, a histogram of GFP signal was

332

plotted, and only events with highest fluorescence signal were collected (Figure 3C).

333

Samples collected before sorting and from GFP+ or GFP- sorted nuclei were imaged to calculate

334

the extent of Sun1-GFP+ nuclei enrichment. GFP signal was visible in Sun1-GFP sorted nuclei,

335

and no GFP signal was found in the gating for GFP- nuclei (Figure 3D). Our results indicate

336

that this method allows enrichment above 90% for astrocytes and microglia nuclei (Figure 3E).

337

We found that this high enrichment of GFP+ nuclei depends heavily on the absence of nuclei

338

doublets or clusters. As an example, we determined enrichment for astrocyte nuclei with and

339

without the second gating for doublets and found that the purity of Sun1-GFP nuclei improved

340

by 10% when doublets and clusters were excluded (Figure 3F).

341
342
343
344
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345
346

Figure 3. High enrichment of GFP tagged nuclei obtained through FANS. Representative

347

images of the gating settings used to sort Sun1-GFP nuclei. (A) Gating set to discard clumps,

348

events higher in the forward and back scattered channels; (B) population gated in A was then

349

plotted according to EGFP signal intensity and area to identify nuclei singlets and remove

350

doublets; (C) only nuclei singlets from the black box in B with higher EGFP signal intensity

351

(shown in green) are collected, whereas events with lower EGFP signal (grey) are discarded.
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352

(D) DAPI-stained nuclei obtained before sorting or from sorted GFP- and GFP+ collection tubes

353

(E) Enrichment of Sun1-GFP+ sorted astrocyte (AST) or microglia (MG) nuclei (mean +/-

354

SEM, n=6-8). (F) Enrichment of Sun1-GFP+ sorted nuclei as % of GFP tagged nuclei for

355

astrocyte nuclei with or without gating to remove doublets, ***p<0.0001 unpaired t-test (n=6).

356
357

3.2 RNA extraction yield and quality.

358

To maintain high RNA quality and yield, we paused sorting a handful of times to vortex the

359

collection tube to ensure proper mixing of the nuclei in sheath solution with the lysis buffer.

360

Collection in the lysis buffer facilitates downstream processing, as lysis of the nuclei starts as

361

they are collected and does not require additional concentration steps before RNA extraction.

362

We also added 2-mercaptoethanol (2% final concentration) to the collection tube to account

363

for the volume of sheath solution containing the sorted nuclei. The RNA yield varied depending

364

on the type of cell: 70 – 240 ng of RNA for astrocytes, 170 – 370 ng for OPCs/oligodendrocytes

365

and 57 – 95 ng for microglia (Figure 4A). However, it is important to point out that these

366

numbers cannot be compared directly because the samples used for each cell type were

367

collected from different brain regions, at different time points. Moreover, each model uses

368

distinctive Cre driver lines with presumably different Cre expression. The regimen of

369

tamoxifen administration was also very different between animal models.

370

Interestingly, in the case of astrocytes and microglia, the amount of RNA obtained appears to

371

be determined by the cell type and not the number of nuclei. To better visualize the cell type-

372

specific differences in the RNA yield obtained, we calculated the amount of RNA per nuclei

373

and saw that microglia have significantly lower RNA content per nuclei and the results are less

374

variable compared to astrocytes and OPC/Oligodendrocytes (Figure 4B). These results indicate

375

that there might be cell type-specific differences in the RNA content in the nuclei of glial cells.

376

To validate the quality of RNA extraction, we selected astrocytes and OPC/Oligodendrocytes
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377

for RIN analysis. Electrogram profiles and RIN from the Agilent bioanalyzer indicate that our

378

protocol produced high integrity RNA (Figure 4C), as all RNA samples are above the quality

379

threshold of a RIN above 7 for the glial cell types analyzed (Figure 4D). Therefore, despite

380

differences in RNA content, enough high-quality RNA for further transcriptomic analysis can

381

be obtained for each glial cell type with this method.

382
383

384
385

Figure 4. High RNA yield and quality from Sun1-GFP nuclei obtained through FANS. (A)

386

Correlation between RNA extracted from the respective nuclei collected for astrocytes (AST)

387

(p=0.0763), OPC/Oligodendrocytes (OPC/OLs) (p=0.0223) and microglia (MG) (p=0.4455).

388

(B) Calculated RNA content per nuclei obtained for every sorting session for each cell type

389

analyzed, ***p<0.0001 One-way ANOVA with Tukey’s Multiple comparisons (AST n=10,

390

OPC/OL n=8, MG n=6). (C) Representative electrogram and gel view from Agilent

391

Bioanalyzer used for RIN analysis. (D) Quality of RNA extraction as shown in RIN values of

392

RNA samples extracted from astrocytes and OPC/OLs sorted nuclei (n=4).

393
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394

3.3 Cell type-specific gene expression and chromatin availability.

395

We performed RNA-seq with three biological replicates using the RNA from sorted nuclei of

396

astrocytes, microglia, and OPC/Oligodendrocytes. To further validate our approach, we

397

compared the expression of well-known cell type-specific genes using the RNA-seq

398

transcriptome data. Hierarchical clustering of these genes shows that indeed, the cell type-

399

specific sets are enriched in their corresponding sample (Figure 5A). To further characterize

400

our enriched populations, we used sets of transcription factors differentially expressed in each

401

glial cell type, previously reported by Zhang et al., 2014 (Figure 5B), and observed distinct

402

enrichment for the corresponding glial cell type and appropriate clustering of the samples. We

403

also observe that astrocytes and OPC/Oligodendrocytes samples show higher similarity,

404

compared to microglia. The distinct clustering of each cell type based on gene expression

405

further validates that we obtained an enriched population of the desired glial cells, and that our

406

optimized method provides a useful tool to analyze the transcriptome of enriched nuclei

407

populations.

408

Astrocytes and microglia were selected for the validation of cell type-specific chromatin

409

accessibility on sorted nuclei. We therefore performed ATAC-seq with two biological

410

replicates using the sorted nuclei of astrocytes and microglia. To visualize the tracks of ATAC-

411

seq, we selected cell-type specific genes that showed differential gene expression in our RNA-

412

seq data. Consistent with cell type-specific gene expression, ATAC-seq also showed the

413

distinct cell type-specific chromatin accessibility peaks for microglia and astrocytes in selected

414

regions. For example, astrocytes specific genes Aldh1l1, Aqp4 and Gfap showed more open

415

chromatin in astrocytes but not in microglia. Similarly, microglia specific genes C1q, Csf1r

416

and Trem2 showed more open chromatin only in microglia (Figure 5C). Similar to the

417

transcriptomic results, chromatin accessibility assays reveal patterns characteristic of enriched
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418

nuclei populations, confirming that our approach is suitable for omics analysis of the chromatin

419

as well as transcriptome.

420
421

Figure 5. Differential expression and chromatin availability of cell type-specific genes

422

determined by RNA-seq and ATAC-seq using sorted nuclei. (A) Heatmap of RNA-seq

423

expression results with single linkage clustering and Spearman rank correlation shows higher

424

expression of the corresponding cell type-specific genes for astrocytes (AST),

425

OPC/Oligodendrocytes (OPC/OLs) and microglia (MG). (B) Enriched expression in the

426

corresponding glial cell of transcription factors reported in (Zhang et al., 2014) to be cell type-

427

enriched. (C) Chromatin availability from ATAC-seq analysis show distinct accessibility peak

428

pattern in cell type-specific genes with differential expression determined with RNA-seq.

429
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430
431

4. CONCLUSION

432

We present an optimized method for nuclei isolation and sorting of fluorescently tagged nuclei,

433

applicable to a diverse population of cell types. Our method takes advantage of commercially

434

available mouse lines that allow fluorescent labelling of nuclei from a variety of cell types of

435

interest, avoiding the use of fixatives, antibodies or DNA dyes. The protocol used here for

436

nuclei isolation and sorting consists of optimized, rapid and fewer manipulation steps, avoids

437

cell dissociation stress while still yielding highly purified cell type-specific nuclei in sufficient

438

quantity and quality for omics applications. This optimized protocol will therefore be a useful

439

reference for the investigation of chromatin structure and gene expression in specific mouse

440

brain cell types of interest.
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458

Supplementary table 1: list of primer sequences
Genotyping primer

Forward Sequence 5’à3’

Reverse Sequence 5’à3’

Sun1-GFP

AAG GGA GCT GCA GTG GAG TA

CGG GCC ATT TAC CGT AAG TTA T

Sox10-CreERT

CAC CTA GGG TCT GGC ATG T

CAG GTT TTG GTG CAC AGT CA

Glast-CreERT

ACA ATC TGG CCT GCT ACC AAA GC

CCA GTG AAA CAG CAT TGC TGT C

Cx3cr1-CreERT

AAG ACT CAC GTG GAC CTG CT

CGGTTATTCAACTTGCAC CA

459
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